the present invention relates to thiazolidinedione derivatives of omega - 3 fatty acids as insulin sensitizers , and their use in treating type2 diabetes , obesity , hypertriglyceridemia , cardiovascular diseases , metabolic diseases , inflammation , renal anemia , and / or alzheimer &# 39 ; s disease : and for modulating activity of peroxisome proliferator - activated receptors .